Stamford Pharmaceuticals announces the first patient on-study to be treated with ASN-002
Stamford Pharmaceuticals Inc and Ascend Biopharmaceuticals Ltd (its Australian affiliate) announces the first patient on-study to be treated with ASN-002 […]
Stamford Pharmaceuticals Inc and Ascend Biopharmaceuticals Ltd (its Australian affiliate) announces the first patient on-study to be treated with ASN-002 […]
Stamford Pharmaceuticals Inc Announces Clinical Collaboration with Roche to Evaluate SP-002 in Combination with vismodegib in Patients with basal cell […]
Stamford Pharmaceuticals announced today receiving ethics approval for the Pilot phase of its registration program. The program will commence initially […]
August 1st, 2019 Stamford Pharmaceuticals announced today the engagement with Assoc. Professors Greg Siller and Sherrif Ibrahim to serve as […]